Clinical Trials to Preserve Beta Cell Function and Delay Onset of Symptomatic Disease in the At-risk Setting for Type 1 Diabetes (T1D)

JUVENILE DIABETES RESEARCH FOUNDATION- JDRF

Objecte

JDRF is soliciting expressions of interest (EOI) for performing secondary prevention clinical trials to preserve beta cell function and delay the onset of symptomatic disease. These EOIs may include proof-of-concept clinical trials with existing and/or novel therapies and with combination therapies that target different aspects of beta cell dysfunction and loss.

Termini IISPV

Declaration of interest: IISPV’s deadline: 06/30/2014 (europa@iispv.cat) LOI: 07/4/2014 Full proposal: IISPV’s deadline: Application 30/9/2014

Termini Oficial

E/LOI Deadline 7/11/2014  – Application Deadline 10/1/2014

Estàs interessat?

Omple el següent formulari per rebre més informació: